glp 1 bacteria A surprising role for enteroendocrine cells and GLP-1 in regulating intestinal inflammation Your gut already produces GLP-1
Description
Beyond obesity and type 2 diabetes, the therapeutic potential of GLP-1 RAs extends to a range of conditions such as cardiovascular disease, liver disease, neurodegenerative disease, and substance abuse disorders
USA 110 , 52115216 (2013)
The interaction concerns apply fully to Hashimoto patients
283 (4): E745E752
Human studies have demonstrated that for those with obesity, prediabetes, or early-stage T2D, liraglutide slows a decline of memory function independent of weight reduction
